Following a meal, when blood sugar begins to rise, GLP-1 also rises and binds to its receptors in the pancreas, stimulating the production and release of insulin, which lowers blood sugar by facilitating its movement from the bloodstream into the tissues of the body
Retatrutide (Maximum dose: 12 mg weekly) Retatrutide shares the class-wide gastrointestinal side effects: nausea (43%), diarrhea (33%), vomiting, and constipation, occurring at rates broadly comparable to semaglutide
urine, sweat, saliva, reproductive fluids and breath (as body fluids draw liquid from plasma in the bloodstream)
Insert the needle at the angle specified in the device IFU (typically 4590 degrees, depending on needle length and body composition)
Warnings If you are pregnant, nursing, taking medication or have a medical condition, consult your healthcare practitioner before use